HANSOH PHARMAC (Germany) Top Insiders

3KY Stock  EUR 1.97  0.05  2.48%   
HANSOH PHARMAC employs about 10.8 K people. The company is managed by 14 executives with a total tenure of roughly 116 years, averaging almost 8.0 years of service per executive, having 770.21 employees per reported executive. Examination of HANSOH PHARMAC's management performance can provide insight into the company performance.
Huijuan Zhong  CEO
Chief Executive Officer, Executive Chairlady of the Board
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HANSOH PHARMAC HD 00001. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

HANSOH PHARMAC Management Team Effectiveness

The company has return on total asset (ROA) of 0.063 % which means that it generated a profit of $0.063 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1366 %, meaning that it generated $0.1366 on every $100 dollars invested by stockholders. HANSOH PHARMAC's management efficiency ratios could be used to measure how well HANSOH PHARMAC manages its routine affairs as well as how well it operates its assets and liabilities.

HANSOH PHARMAC Workforce Comparison

HANSOH PHARMAC HD 00001 is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 62,598. HANSOH PHARMAC retains roughly 10,783 in number of employees claiming about 17% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28.

HANSOH PHARMAC HD Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. HANSOH PHARMAC HD Price Series Summation is a cross summation of HANSOH PHARMAC price series and its benchmark/peer.

HANSOH PHARMAC Notable Stakeholders

A HANSOH PHARMAC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as HANSOH PHARMAC often face trade-offs trying to please all of them. HANSOH PHARMAC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting HANSOH PHARMAC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Huijuan ZhongChief Executive Officer, Executive Chairlady of the BoardProfile
Min HuVice PresidentProfile
Shengli ZhongVice President Joint Company SecretaryProfile
Chuanhe XuSenior Vice PresidentProfile
Sheung ChanNon-Executive Independent DirectorProfile
Rudi BaoSenior Vice PresidentProfile
Chunhua ZhongSenior Vice PresidentProfile
Guoqiang LinNon-Executive Independent DirectorProfile
Dongtao YangNon-Executive Independent DirectorProfile
Yuan SunExecutive DirectorProfile
Cuifang MaNon-Executive DirectorProfile
Gongzheng WuSenior Vice PresidentProfile
Aifeng LyuExecutive DirectorProfile
Yan LiJoint company secretaryProfile

About HANSOH PHARMAC Management Performance

The success or failure of an entity such as HANSOH PHARMAC HD often depends on how effective the management is. HANSOH PHARMAC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of HANSOH management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the HANSOH management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients in the Peoples Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd. HANSOH PHARMAC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11645 people.

HANSOH PHARMAC Workforce Analysis

Traditionally, organizations such as HANSOH PHARMAC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare HANSOH PHARMAC within its industry.

HANSOH PHARMAC Manpower Efficiency

Return on HANSOH PHARMAC Manpower

Revenue Per Employee924.4K
Revenue Per Executive712M
Net Income Per Employee238.3K
Net Income Per Executive183.6M

Complementary Tools for HANSOH Stock analysis

When running HANSOH PHARMAC's price analysis, check to measure HANSOH PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HANSOH PHARMAC is operating at the current time. Most of HANSOH PHARMAC's value examination focuses on studying past and present price action to predict the probability of HANSOH PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HANSOH PHARMAC's price. Additionally, you may evaluate how the addition of HANSOH PHARMAC to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device